Montastruc JL - Search Results

1

A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollis.

Brefel-Courbon C, Simonetta-Moreau M, Moré C, Rascol O, Clanet M, Montastruc JL, Lapeyre-Mestre M. Brefel-Courbon C, et al. Among authors: montastruc jl. Clin Neuropharmacol. 2000 Jul-Aug;23(4):203-7. doi: 10.1097/00002826-200007000-00006. Clin Neuropharmacol. 2000. PMID: 11020124 Clinical Trial.

2

Long-term treatment of Parkinson's disease with bromocriptine.

Rascol A, Guiraud B, Montastruc JL, David J, Clanet M. Rascol A, et al. Among authors: montastruc jl. J Neurol Neurosurg Psychiatry. 1979 Feb;42(2):143-50. doi: 10.1136/jnnp.42.2.143. J Neurol Neurosurg Psychiatry. 1979. PMID: 422961 Free PMC article.

3

[Antiparkinsonian drug consumption in a University Hospital Center 1981-1990].

Lapeyre-Mestre M, Chave B, Rascol O, Senard JM, Lafont J, Montastruc JL. Lapeyre-Mestre M, et al. Among authors: montastruc jl. Therapie. 1992 Sep-Oct;47(5):444-5. Therapie. 1992. PMID: 1299997 French. No abstract available.

4

A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's disease.

Montastruc JL, Rascol O, Senard JM, Rascol A. Montastruc JL, et al. J Neurol Neurosurg Psychiatry. 1992 Jul;55(7):630-1. doi: 10.1136/jnnp.55.7.630-a. J Neurol Neurosurg Psychiatry. 1992. PMID: 1386383 Free PMC article. No abstract available.

5

Naloxone or haloperidol but not yohimbine reverse apomorphine-induced respiratory depression.

Montastruc JL, Rascol O, Montastruc P. Montastruc JL, et al. Among authors: montastruc p. Clin Neuropharmacol. 1992 Oct;15(5):404-7. doi: 10.1097/00002826-199210000-00009. Clin Neuropharmacol. 1992. PMID: 1423340

6

Parkinson's disease and weight loss: a study with anthropometric and nutritional assessment.

Durrieu G, LLau ME, Rascol O, Senard JM, Rascol A, Montastruc JL. Durrieu G, et al. Among authors: montastruc jl. Clin Auton Res. 1992 Jun;2(3):153-7. doi: 10.1007/BF01818955. Clin Auton Res. 1992. PMID: 1498561

7

[Development of antibiotic consumption at the Regional University Hospital Center of Toulouse from 1980 to 1989].

Lapeyre-Mestre M, Chave B, Montastruc JL. Lapeyre-Mestre M, et al. Among authors: montastruc jl. Therapie. 1992 Jan-Feb;47(1):57-61. Therapie. 1992. PMID: 1523596 French.

8

Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine.

Rascol O, Sabatini U, Chollet F, Celsis P, Montastruc JL, Marc-Vergnes JP, Rascol A. Rascol O, et al. Among authors: montastruc jl. Arch Neurol. 1992 Feb;49(2):144-8. doi: 10.1001/archneur.1992.00530260044017. Arch Neurol. 1992. PMID: 1736846

9

Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic study.

Montastruc JL, Rascol O, Senard JM, Gualano V, Bagheri H, Houin G, Lees A, Rascol A. Montastruc JL, et al. Clin Neuropharmacol. 1991 Oct;14(5):432-7. doi: 10.1097/00002826-199110000-00007. Clin Neuropharmacol. 1991. PMID: 1742752

10

Locally activated coagulation induced by a peripheral endovenous catheter.

Sié P, Camez A, Derobert E, Rascol O, Montastruc JL, Boneu B. Sié P, et al. Among authors: montastruc jl. Thromb Res. 1991 Dec 15;64(6):775-82. doi: 10.1016/0049-3848(91)90079-c. Thromb Res. 1991. PMID: 1798968 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

898 results

Search Page

Filters